154 related articles for article (PubMed ID: 15612886)
1. Oxazolone-induced murine model of ulcerative colitis.
Wang X; Ouyang Q; Luo WJ
Chin J Dig Dis; 2004; 5(4):165-8. PubMed ID: 15612886
[TBL] [Abstract][Full Text] [Related]
2. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
Daniel C; Sartory NA; Zahn N; Schmidt R; Geisslinger G; Radeke HH; Stein JM
Mol Immunol; 2007 Jul; 44(13):3305-16. PubMed ID: 17475330
[TBL] [Abstract][Full Text] [Related]
3. Helminth infection enhances disease in a murine TH2 model of colitis.
Hunter MM; Wang A; McKay DM
Gastroenterology; 2007 Apr; 132(4):1320-30. PubMed ID: 17408663
[TBL] [Abstract][Full Text] [Related]
4. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.
Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
6. Biomechanical changes in oxazolone-induced colitis in BALB/C mice.
Yang J; Zhao J; Nakaguchi T; Gregersen H
J Biomech; 2009 May; 42(7):811-7. PubMed ID: 19264309
[TBL] [Abstract][Full Text] [Related]
7. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines.
Rosen MJ; Chaturvedi R; Washington MK; Kuhnhein LA; Moore PD; Coggeshall SS; McDonough EM; Weitkamp JH; Singh AB; Coburn LA; Williams CS; Yan F; Van Kaer L; Peebles RS; Wilson KT
J Immunol; 2013 Feb; 190(4):1849-58. PubMed ID: 23303670
[TBL] [Abstract][Full Text] [Related]
8. Differential induction of cutaneous TNF-alpha and IL-6 by topically applied chemicals.
Holliday MR; Corsini E; Smith S; Basketter DA; Dearman RJ; Kimber I
Am J Contact Dermat; 1997 Sep; 8(3):158-64. PubMed ID: 9249285
[TBL] [Abstract][Full Text] [Related]
9. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa.
Zwolinska-Wcislo M; Brzozowski T; Budak A; Kwiecien S; Sliwowski Z; Drozdowicz D; Trojanowska D; Rudnicka-Sosin L; Mach T; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2009 Mar; 60(1):107-18. PubMed ID: 19439813
[TBL] [Abstract][Full Text] [Related]
10. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
11. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory properties of IL-4 in the intestinal microenvironment.
Van Kampen C; Gauldie J; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G111-7. PubMed ID: 15591585
[TBL] [Abstract][Full Text] [Related]
13. [Study the effect and mechanism of thalidomide in model of inflammatory bowed disease].
Wang X; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):548-51. PubMed ID: 16078585
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
Pender SL; Chance V; Whiting CV; Buckley M; Edwards M; Pettipher R; MacDonald TT
Gut; 2005 Aug; 54(8):1114-20. PubMed ID: 16009684
[TBL] [Abstract][Full Text] [Related]
15. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
[TBL] [Abstract][Full Text] [Related]
16. Chemically induced mouse models of intestinal inflammation.
Wirtz S; Neufert C; Weigmann B; Neurath MF
Nat Protoc; 2007; 2(3):541-6. PubMed ID: 17406617
[TBL] [Abstract][Full Text] [Related]
17. Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium.
Xu L; Yang ZL; Li P; Zhou YQ
Phytomedicine; 2009 Oct; 16(10):989-95. PubMed ID: 19386481
[TBL] [Abstract][Full Text] [Related]
18. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
19. Oxazolone-Induced Colitis as a Model of Th2 Immune Responses in the Intestinal Mucosa.
Weigmann B; Neurath MF
Methods Mol Biol; 2016; 1422():253-61. PubMed ID: 27246039
[TBL] [Abstract][Full Text] [Related]
20. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
